The U.S. Food and Drug Administration has approved a new acid reflux medication called Kapidex. The delayed-release proton-pump inhibitor (PPI) is made by Takeda, the same company that manufactures Prevacid, a PPI that will go off patent this year and face competition from cheaper generic meds. Studies suggest the new drug is not much more powerful than Prevacid. A study found that a 60-milligram dosage of Kapidex was similarly effective as a 30-milligram dose of its predecessor.
Read moreIn March, Takeda Pharmaceuticals, the maker of the Proton Pump Inhibitor (PPI) Kapidex, changed the name of this medication to Dexilant.... Read more »
Drugmaker Takeda Pharmaceuticals has announced that it has changed the name of the drug Kapidex to Dexilant (dexlasoprazole) to reduce the likelihood... Read more »
The acid reflux medication Kapidex has been renamed Dexilant. The name change comes because the drug was being confused with cancer and other... Read more »
Source: ADAM Encyclopedia
AntacidsAntacids neutralize acids in the stomach, and are the drugs of choice for mild GERD symptoms. They may also stimulate the defensive systems... Read more »